Product image of Meloxicam Mylan (Meloxicam) supplied by GNH India

Meloxicam Mylan

Active Ingredient:
Meloxicam
Origin:
EU

Meloxicam Mylan (Meloxicam)

Meloxicam, the active ingredient in Meloxicam Mylan, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral dosage form for oral use. It is indicated for the relief of pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute musculoskeletal pain.
GNH India supplies Meloxicam Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Mylan Pharmaceuticals S.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Meloxicam Mylan belongs to the NSAID class and acts on inflammatory pathways that underlie several musculoskeletal disorders.

  • Osteoarthritis: reduces joint pain and swelling, improving mobility in patients with osteoarthritis.
  • Rheumatoid arthritis: alleviates chronic inflammation and joint damage associated with rheumatoid arthritis.
  • Ankylosing spondylitis: diminishes spinal inflammation and stiffness in ankylosing spondylitis.
  • Acute pain: provides rapid relief of moderate to severe acute musculoskeletal pain.

How It Works

  • Meloxicam selectively inhibits cyclooxygenase‑2 (COX‑2) enzymes, with lesser effect on COX‑1, leading to decreased conversion of arachidonic acid to prostaglandins. The reduction in prostaglandin synthesis diminishes inflammation, pain, and fever at sites of tissue injury.

Side Effects

Adverse reactions may vary in frequency and severity.

Common Side Effects

  • Gastrointestinal discomfort or dyspepsia.
  • Nausea or vomiting.
  • Diarrhea.
  • Headache.
  • Dizziness.
  • Mild skin rash.

Serious or Rare Side Effects

  • Gastrointestinal ulceration or bleeding.
  • Cardiovascular events such as myocardial infarction or stroke.
  • Elevated liver enzymes or hepatic injury.
  • Severe cutaneous reactions (e.g., Stevens‑Johnson syndrome).
  • Acute renal impairment.
  • Anaphylactic or severe allergic reactions.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for complications.

  • Assess cardiovascular risk: review history of heart disease or stroke before prescribing.
  • Monitor renal function: especially in patients with existing kidney disease or dehydration.
  • Avoid in known NSAID hypersensitivity: discontinue if allergic reactions occur.
  • Use the lowest effective dose: to limit gastrointestinal and cardiovascular hazards.
  • Concurrent anticoagulant use: increase bleeding risk, require close monitoring.
  • Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Meloxicam can interact with several drug classes, altering efficacy or safety.

Major Interactions (Avoid)

  • Anticoagulants (e.g., warfarin): heightened risk of serious bleeding.
  • Selective serotonin reuptake inhibitors (SSRIs): increased gastrointestinal bleed potential.
  • Lithium: meloxicam may raise lithium serum concentrations.
  • Methotrexate: reduced renal clearance leading to toxicity.
  • Cyclosporine: additive nephrotoxic effect.

Moderate Interactions (Monitor Closely):\n- ACE inhibitors or ARBs: may impair renal function when combined.

  • Diuretics: risk of renal impairment and electrolyte disturbances.
  • Beta‑blockers: possible masking of hypertension symptoms.
  • Corticosteroids: additive risk of gastrointestinal ulceration.
  • Alcohol: enhances gastric irritation and bleeding risk.

Frequently Asked Questions

Meloxicam Mylan is an oral NSAID prescribed to relieve pain and inflammation in conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute musculoskeletal pain. It works by targeting inflammatory pathways that contribute to joint swelling and discomfort.

Meloxicam selectively blocks the cyclooxygenase‑2 (COX‑2) enzyme, reducing the production of prostaglandins that mediate inflammation, pain, and fever. By sparing COX‑1 to a greater extent, it aims to lessen gastrointestinal side effects while providing anti‑inflammatory benefits.

The appropriate dose of meloxicam is determined by the prescribing healthcare professional based on the patient’s condition, age, renal function, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Safety of meloxicam during pregnancy and lactation has not been firmly established. It is generally advised to avoid use unless the potential benefit outweighs the risk, and decisions should be made in consultation with a qualified healthcare provider.

To request Meloxicam Mylan, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meloxicam offers a longer half‑life and preferential COX‑2 inhibition compared with many traditional NSAIDs, which may allow once‑daily dosing and potentially lower gastrointestinal risk. However, cardiovascular and renal safety considerations remain similar to other NSAIDs, and individual patient factors guide drug selection.

Store Meloxicam Mylan at ambient temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Meloxicam Mylan is taken orally, usually with a full glass of water. It may be taken with or without food, but patients who experience stomach upset may benefit from taking it with meals. Swallow tablets whole; do not crush or chew them.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, severe skin reactions (e.g., Stevens‑Johnson syndrome), liver injury, acute kidney damage, and anaphylaxis. Patients should seek immediate medical attention if they notice signs like severe abdominal pain, black stools, chest pain, sudden swelling, or rash.

Meloxicam should be avoided in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, significant renal or hepatic impairment, and patients who are in the third trimester of pregnancy. A healthcare professional must evaluate suitability before prescribing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Meloxicam

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT